acitretin has been researched along with Vulvar Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaj, V; Barrett, P; Naidoo, K; Tighe, I | 1 |
| Azevedo, F; Bettencourt, H; Ferreira, O; Lisboa, C; Pedrosa, AF | 1 |
| Baudin, M; Bousema, MT; Geiger, JM; Romppanen, U; Vähä-Eskeli, K; Vartiainen, J; Vuopala, S | 1 |
1 trial(s) available for acitretin and Vulvar Diseases
| Article | Year |
|---|---|
Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study.
Topics: Acitretin; Double-Blind Method; Female; Humans; Lichenoid Eruptions; Middle Aged; Vulvar Diseases | 1994 |
2 other study(ies) available for acitretin and Vulvar Diseases
| Article | Year |
|---|---|
Acitretin as a successful treatment for Hailey-Hailey disease.
Topics: Acitretin; Aged; Female; Humans; Keratolytic Agents; Leg Dermatoses; Pemphigus, Benign Familial; Thigh; Vulvar Diseases | 2019 |
Primary Langerhans cell histiocytosis of the vulva: acitretin as a glucocorticoid-sparing agent.
Topics: Acitretin; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Keratolytic Agents; Prednisolone; Scalp Dermatoses; Skin Diseases; Vulvar Diseases | 2014 |